SLC39A11 and Alzheimer disease: Notable ASEs include an increase in the upstream length of exon 26 of DEPDC5 in AD (P.ADJ = 6.47E-6), an increase in the downstream length of exon 3 of SLC39A11 in AD (p.adj = 6.38E-5), MXE of MTMR14 (p.adj = 1.97E-6), RI of intron 16 of NPAS2 (p.adj = 6.38E-9), SE of exon seven of RUFY1 (p.adj = 7.55E-7), and SE of exon six of SLC27A1 (p.adj = 6.06E-9; Figures 2C–G).